Metraipolis › archive › dc_e3472da2995d

Serum Hepcidin as a Biomarker of Subclinical Atherosclerosis in Peritoneal Dialysis: A Cross-Sectional Study — Europe PMC PMID:41302941

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41302941
DOI
10.3390/jcm14227905
License (as archived)
solo-consultazione
Archived
2026-11-08T17:27:28.931Z
SHA-256 of the archived text
5204fecec510b7ee462c933e9c27880f1395b2b34849b2d390e91d614548fd4c
Stable URL of this page
https://metraipolis.com/documento/dc_e3472da2995d

How to cite

Serum Hepcidin as a Biomarker of Subclinical Atherosclerosis in Peritoneal Dialysis: A Cross-Sectional Study — Europe PMC PMID:41302941 — Europe PMC (en), https://europepmc.org/article/MED/41302941 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e3472da2995d (Metraipolis archive dc_e3472da2995d, sha256 5204fecec510b7ee462c933e9c27880f1395b2b34849b2d390e91d614548fd4c)
BibTeX
@misc{dce3472da2995d,
  title = {Serum Hepcidin as a Biomarker of Subclinical Atherosclerosis in Peritoneal Dialysis: A Cross-Sectional Study — Europe PMC PMID:41302941},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41302941},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e3472da2995d; sha256 5204fecec510b7ee462c933e9c27880f1395b2b34849b2d390e91d614548fd4c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41302941. Agents can read the archived copy with the MCP tool read_document.